US begins 1st human trials of pig organ transplants
The US just kicked off a bold new clinical trial, transplanting genetically modified pig kidneys into people for the first time.
It's a big deal for anyone following medical breakthroughs—this could be a game-changer for the thousands stuck on organ waitlists.
The first surgery happened at NYU Langone Health, led by Dr. Robert Montgomery, using organs produced by United Therapeutics.
A potential breakthrough in organ transplantation
The study starts with six patients and could expand to 50 if things go well.
Earlier attempts showed some pig kidneys can work in humans for months, but results have been mixed.
With over 100,000 Americans waiting for transplants (most need kidneys), this approach—making pig organs more human-like to avoid rejection—offers real hope.
Plus, biotech company eGenesis is gearing up for its own similar trial soon, so expect even more progress ahead.